Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-09 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-09 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-09 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-09 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |